Novel
Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.

Equitable Allocation of COVID-19 Vaccines in the United States

Schmidt, H., Weintraub, R., Williams, M. A., Miller, K., Buttenheim, A., Sadecki, E., Wu, H., Doiphode, A., Nagpal, N., Gostin, L. O., Shen, A. A.

Release Date:

Peer Review Study

Vaccination
Social and Community Context
Tools Included
Outside U.S.
ACCESS RESOURCE
Network of people

Partnerships and Collaboration

This article presents findings from a study that assessed published COVID-19 vaccine allocation plans for the Center for Disease Control and Prevention’s (CDC) 64 jurisdictions. The analysis reflects assessments of the plans between November 2020 and March 2021. The authors question whether the plans prioritized zip codes based on calculated disadvantage indices, which are based on area-level indicators (e.g., U.S. Census data). By the end of the period under investigation, 37 jurisdictions had adopted disadvantage scales. Key themes include: (1) Prioritizing disadvantaged groups, (2) Defining priority groups or areas, (3) Tailoring outreach and communication, (4) Planning the location of dispensing sites, and (5) Monitoring receipt of the COVID-19 vaccine.

Resource Details

Outcomes of Interest

Advancing Racial Equity

Priority Population(s)

Setting(s) of Implementation

Community

Geographic Area of Implementation

Implementation Period

2020-2021